Four weeks supplementation with Lactobacillus paracasei subsp. paracasei L. casei W8® shows modest effect on triacylglycerol in young healthy adults

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Four weeks supplementation with Lactobacillus paracasei subsp. paracasei L. casei W8® shows modest effect on triacylglycerol in young healthy adults. / Bjerg, Anne Toksvig; Kristensen, Mette Bredal; Ritz, Christian; Stark, K D; Holst, Jens Juul; Leser, Thomas Dyrmann; Wellejus, Anja; Astrup, Arne.

In: Beneficial Microbes, Vol. 6, No. 1, 2015, p. 29-39.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Bjerg, AT, Kristensen, MB, Ritz, C, Stark, KD, Holst, JJ, Leser, TD, Wellejus, A & Astrup, A 2015, 'Four weeks supplementation with Lactobacillus paracasei subsp. paracasei L. casei W8® shows modest effect on triacylglycerol in young healthy adults', Beneficial Microbes, vol. 6, no. 1, pp. 29-39. https://doi.org/10.3920/BM2014.0058

APA

Bjerg, A. T., Kristensen, M. B., Ritz, C., Stark, K. D., Holst, J. J., Leser, T. D., ... Astrup, A. (2015). Four weeks supplementation with Lactobacillus paracasei subsp. paracasei L. casei W8® shows modest effect on triacylglycerol in young healthy adults. Beneficial Microbes, 6(1), 29-39. https://doi.org/10.3920/BM2014.0058

Vancouver

Bjerg AT, Kristensen MB, Ritz C, Stark KD, Holst JJ, Leser TD et al. Four weeks supplementation with Lactobacillus paracasei subsp. paracasei L. casei W8® shows modest effect on triacylglycerol in young healthy adults. Beneficial Microbes. 2015;6(1):29-39. https://doi.org/10.3920/BM2014.0058

Author

Bjerg, Anne Toksvig ; Kristensen, Mette Bredal ; Ritz, Christian ; Stark, K D ; Holst, Jens Juul ; Leser, Thomas Dyrmann ; Wellejus, Anja ; Astrup, Arne. / Four weeks supplementation with Lactobacillus paracasei subsp. paracasei L. casei W8® shows modest effect on triacylglycerol in young healthy adults. In: Beneficial Microbes. 2015 ; Vol. 6, No. 1. pp. 29-39.

Bibtex

@article{be4efae936cb4cbe80b980d263db2f5d,
title = "Four weeks supplementation with Lactobacillus paracasei subsp. paracasei L. casei W8{\circledR} shows modest effect on triacylglycerol in young healthy adults",
abstract = "The microbiota has been shown to have the potential to affect appetite and blood lipids positively in animal studies. We investigated if four weeks supplementation with Lactobacillus paracasei subsp. paracasei L. casei W8{\circledR} (L. casei W8) had an effect on subjective appetite sensation, ad libitum energy intake, glucagon-like peptide 1 (GLP- 1), glucose and insulin response in humans. Secondarily, we explored potential effects on blood lipids, fatty acids and stearoyl-CoA desaturase-1 (SCD1) activity in humans as well as SCD1 expression in piglets given L. casei W8 for two weeks. 64 healthy participants completed the double-blinded, randomised, controlled, parallel four weeks study with supplementation of L. casei W8 (1010 cfu) or placebo capsules. A meal test was conducted before and after the intervention, where subjective appetite, ad libitum energy intake, GLP-1, glucose and insulin response were measured. Additionally fasting blood lipids and fatty acids concentrations were measured. Sixteen piglets were randomised into two groups: L. casei W8 (1010 cfu/day) as top dressing on morning fed or no treatment. After two weeks piglets were sacrificed and tissue from ileum, jejunum and skeletal muscle were sampled for mRNA analyses of SCD1 expression. Compared to placebo, L. casei W8 did not affect appetite, ad libitum energy intake, GLP-1, glucose and insulin response and total, high-density or low-density lipoprotein cholesterol levels after four weeks intervention. Triacylglycerol decreased in the L. casei W8 group compared to placebo at week 4 (P=0.03). The C16:1n-7/C16:0 ratio, reflecting SCD1 activity, tended to decrease when having L. casei W8 (P=0.06) compared to placebo. Muscle SCD1 expression decreased in piglets supplemented with L. casei W8 compared to control. In conclusion, supplementation with L. casei W8 did not affect appetite parameters, glucose or insulin responses; but appear to be able to lower triacylglycerol levels, possibly by reducing its production.",
author = "Bjerg, {Anne Toksvig} and Kristensen, {Mette Bredal} and Christian Ritz and Stark, {K D} and Holst, {Jens Juul} and Leser, {Thomas Dyrmann} and Anja Wellejus and Arne Astrup",
note = "CURIS 2015 NEXS 009",
year = "2015",
doi = "10.3920/BM2014.0058",
language = "English",
volume = "6",
pages = "29--39",
journal = "Beneficial Microbes",
issn = "1876-2883",
publisher = "Wageningen Academic Publishers",
number = "1",

}

RIS

TY - JOUR

T1 - Four weeks supplementation with Lactobacillus paracasei subsp. paracasei L. casei W8® shows modest effect on triacylglycerol in young healthy adults

AU - Bjerg, Anne Toksvig

AU - Kristensen, Mette Bredal

AU - Ritz, Christian

AU - Stark, K D

AU - Holst, Jens Juul

AU - Leser, Thomas Dyrmann

AU - Wellejus, Anja

AU - Astrup, Arne

N1 - CURIS 2015 NEXS 009

PY - 2015

Y1 - 2015

N2 - The microbiota has been shown to have the potential to affect appetite and blood lipids positively in animal studies. We investigated if four weeks supplementation with Lactobacillus paracasei subsp. paracasei L. casei W8® (L. casei W8) had an effect on subjective appetite sensation, ad libitum energy intake, glucagon-like peptide 1 (GLP- 1), glucose and insulin response in humans. Secondarily, we explored potential effects on blood lipids, fatty acids and stearoyl-CoA desaturase-1 (SCD1) activity in humans as well as SCD1 expression in piglets given L. casei W8 for two weeks. 64 healthy participants completed the double-blinded, randomised, controlled, parallel four weeks study with supplementation of L. casei W8 (1010 cfu) or placebo capsules. A meal test was conducted before and after the intervention, where subjective appetite, ad libitum energy intake, GLP-1, glucose and insulin response were measured. Additionally fasting blood lipids and fatty acids concentrations were measured. Sixteen piglets were randomised into two groups: L. casei W8 (1010 cfu/day) as top dressing on morning fed or no treatment. After two weeks piglets were sacrificed and tissue from ileum, jejunum and skeletal muscle were sampled for mRNA analyses of SCD1 expression. Compared to placebo, L. casei W8 did not affect appetite, ad libitum energy intake, GLP-1, glucose and insulin response and total, high-density or low-density lipoprotein cholesterol levels after four weeks intervention. Triacylglycerol decreased in the L. casei W8 group compared to placebo at week 4 (P=0.03). The C16:1n-7/C16:0 ratio, reflecting SCD1 activity, tended to decrease when having L. casei W8 (P=0.06) compared to placebo. Muscle SCD1 expression decreased in piglets supplemented with L. casei W8 compared to control. In conclusion, supplementation with L. casei W8 did not affect appetite parameters, glucose or insulin responses; but appear to be able to lower triacylglycerol levels, possibly by reducing its production.

AB - The microbiota has been shown to have the potential to affect appetite and blood lipids positively in animal studies. We investigated if four weeks supplementation with Lactobacillus paracasei subsp. paracasei L. casei W8® (L. casei W8) had an effect on subjective appetite sensation, ad libitum energy intake, glucagon-like peptide 1 (GLP- 1), glucose and insulin response in humans. Secondarily, we explored potential effects on blood lipids, fatty acids and stearoyl-CoA desaturase-1 (SCD1) activity in humans as well as SCD1 expression in piglets given L. casei W8 for two weeks. 64 healthy participants completed the double-blinded, randomised, controlled, parallel four weeks study with supplementation of L. casei W8 (1010 cfu) or placebo capsules. A meal test was conducted before and after the intervention, where subjective appetite, ad libitum energy intake, GLP-1, glucose and insulin response were measured. Additionally fasting blood lipids and fatty acids concentrations were measured. Sixteen piglets were randomised into two groups: L. casei W8 (1010 cfu/day) as top dressing on morning fed or no treatment. After two weeks piglets were sacrificed and tissue from ileum, jejunum and skeletal muscle were sampled for mRNA analyses of SCD1 expression. Compared to placebo, L. casei W8 did not affect appetite, ad libitum energy intake, GLP-1, glucose and insulin response and total, high-density or low-density lipoprotein cholesterol levels after four weeks intervention. Triacylglycerol decreased in the L. casei W8 group compared to placebo at week 4 (P=0.03). The C16:1n-7/C16:0 ratio, reflecting SCD1 activity, tended to decrease when having L. casei W8 (P=0.06) compared to placebo. Muscle SCD1 expression decreased in piglets supplemented with L. casei W8 compared to control. In conclusion, supplementation with L. casei W8 did not affect appetite parameters, glucose or insulin responses; but appear to be able to lower triacylglycerol levels, possibly by reducing its production.

U2 - 10.3920/BM2014.0058

DO - 10.3920/BM2014.0058

M3 - Journal article

C2 - 25245572

VL - 6

SP - 29

EP - 39

JO - Beneficial Microbes

JF - Beneficial Microbes

SN - 1876-2883

IS - 1

ER -

ID: 124504711